These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 23300615
1. In vitro evaluation of ESE-15-ol, an estradiol analogue with nanomolar antimitotic and carbonic anhydrase inhibitory activity. Stander BA, Joubert F, Tu C, Sippel KH, McKenna R, Joubert AM. PLoS One; 2012; 7(12):e52205. PubMed ID: 23300615 [Abstract] [Full Text] [Related]
2. Signaling pathways of ESE-16, an antimitotic and anticarbonic anhydrase estradiol analog, in breast cancer cells. Stander BA, Joubert F, Tu C, Sippel KH, McKenna R, Joubert AM. PLoS One; 2013; 8(1):e53853. PubMed ID: 23382857 [Abstract] [Full Text] [Related]
3. A Combination of an Antimitotic and a Bromodomain 4 Inhibitor Synergistically Inhibits the Metastatic MDA-MB-231 Breast Cancer Cell Line. Mqoco T, Stander A, Engelbrecht AM, Joubert AM. Biomed Res Int; 2019; 2019():1850462. PubMed ID: 31886177 [Abstract] [Full Text] [Related]
4. In vitro assessment of a computer-designed potential anticancer agent in cervical cancer cells. Visagie MH, Jaiswal SR, Joubert AM. Biol Res; 2016 Nov 02; 49(1):43. PubMed ID: 27806731 [Abstract] [Full Text] [Related]
5. Docking, synthesis, and in vitro evaluation of antimitotic estrone analogs. Stander A, Joubert F, Joubert A. Chem Biol Drug Des; 2011 Mar 02; 77(3):173-81. PubMed ID: 21244635 [Abstract] [Full Text] [Related]
6. Ultrastructural changes of erythrocytes in whole blood after exposure to prospective in silico-designed anticancer agents: a qualitative case study. Repsold L, Mqoco T, Wolmarans E, Nkandeu S, Theron J, Piorkowski T, Toit Pd, Papendorp Dv, Joubert AM. Biol Res; 2014 Sep 04; 47(1):39. PubMed ID: 25299962 [Abstract] [Full Text] [Related]
10. Design and synthesis of novel 4-(4-oxo-2-arylthiazolidin-3-yl)benzenesulfonamides as selective inhibitors of carbonic anhydrase IX over I and II with potential anticancer activity. Suthar SK, Bansal S, Lohan S, Modak V, Chaudhary A, Tiwari A. Eur J Med Chem; 2013 Aug 04; 66():372-9. PubMed ID: 23827177 [Abstract] [Full Text] [Related]
11. Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies. Eldehna WM, Al-Ansary GH, Bua S, Nocentini A, Gratteri P, Altoukhy A, Ghabbour H, Ahmed HY, Supuran CT. Eur J Med Chem; 2017 Feb 15; 127():521-530. PubMed ID: 28109946 [Abstract] [Full Text] [Related]
12. Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells. Petreni A, Bonardi A, Lomelino C, Osman SM, ALOthman ZA, Eldehna WM, El-Haggar R, McKenna R, Nocentini A, Supuran CT. Eur J Med Chem; 2020 Mar 15; 190():112112. PubMed ID: 32044580 [Abstract] [Full Text] [Related]
13. 3-Methylthiazolo[3,2-a]benzimidazole-benzenesulfonamide conjugates as novel carbonic anhydrase inhibitors endowed with anticancer activity: Design, synthesis, biological and molecular modeling studies. Alkhaldi AAM, Al-Sanea MM, Nocentini A, Eldehna WM, Elsayed ZM, Bonardi A, Abo-Ashour MF, El-Damasy AK, Abdel-Maksoud MS, Al-Warhi T, Gratteri P, Abdel-Aziz HA, Supuran CT, El-Haggar R. Eur J Med Chem; 2020 Dec 01; 207():112745. PubMed ID: 32877804 [Abstract] [Full Text] [Related]
14. Substituted benzene sulfonamides incorporating 1,3,5-triazinyl moieties potently inhibit human carbonic anhydrases II, IX and XII. Saluja AK, Tiwari M, Vullo D, Supuran CT. Bioorg Med Chem Lett; 2014 Mar 01; 24(5):1310-4. PubMed ID: 24507918 [Abstract] [Full Text] [Related]
15. Novel 4/3-((4-oxo-5-(2-oxoindolin-3-ylidene)thiazolidin-2-ylidene)amino) benzenesulfonamides: Synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies. Eldehna WM, Abo-Ashour MF, Nocentini A, Gratteri P, Eissa IH, Fares M, Ismael OE, Ghabbour HA, Elaasser MM, Abdel-Aziz HA, Supuran CT. Eur J Med Chem; 2017 Oct 20; 139():250-262. PubMed ID: 28802125 [Abstract] [Full Text] [Related]
16. Iodoquinazolinones bearing benzenesulfonamide as human carbonic anhydrase I, II, IX and XII inhibitors: Synthesis, biological evaluation and radiosensitizing activity. Soliman AM, Ghorab MM, Bua S, Supuran CT. Eur J Med Chem; 2020 Aug 15; 200():112449. PubMed ID: 32485534 [Abstract] [Full Text] [Related]
17. Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation. Said MA, Eldehna WM, Nocentini A, Fahim SH, Bonardi A, Elgazar AA, Kryštof V, Soliman DH, Abdel-Aziz HA, Gratteri P, Abou-Seri SM, Supuran CT. Eur J Med Chem; 2020 Mar 01; 189():112019. PubMed ID: 31972394 [Abstract] [Full Text] [Related]
19. Design and synthesis of benzothiazole-6-sulfonamides acting as highly potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII. Ibrahim DA, Lasheen DS, Zaky MY, Ibrahim AW, Vullo D, Ceruso M, Supuran CT, Abou El Ella DA. Bioorg Med Chem; 2015 Aug 01; 23(15):4989-4999. PubMed ID: 26048024 [Abstract] [Full Text] [Related]
20. Exploring new Probenecid-based carbonic anhydrase inhibitors: Synthesis, biological evaluation and docking studies. Mollica A, Costante R, Akdemir A, Carradori S, Stefanucci A, Macedonio G, Ceruso M, Supuran CT. Bioorg Med Chem; 2015 Sep 01; 23(17):5311-8. PubMed ID: 26264840 [Abstract] [Full Text] [Related] Page: [Next] [New Search]